These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 4960046)
1. Pancytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide. Bruce D; Edgcomb JH J Urol; 1967 Mar; 97(3):482-5. PubMed ID: 4960046 [No Abstract] [Full Text] [Related]
2. Severe pancytopenia associated with the use of intravesical thio-TEPA. Watkins WE; Kozak JA; Flanagan MJ J Urol; 1967 Oct; 98(4):470-1. PubMed ID: 4964489 [No Abstract] [Full Text] [Related]
3. Intravesical thiotepa in the treatment of transitional cell bladder carcinoma. Mitchell RJ Br J Urol; 1971 Apr; 43(2):185-8. PubMed ID: 4996214 [No Abstract] [Full Text] [Related]
4. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux]. Rampal M; Alimi JC; Pons G; Fiquet JM J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193 [No Abstract] [Full Text] [Related]
5. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux. Nissenkorn I; Servadio C; Vilikowski E; Glanz I J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177 [TBL] [Abstract][Full Text] [Related]
6. Generalized hypersensitivity reaction to intravesical thiotepa and doxorubicin. Lee M; Sharifi R J Urol; 1987 Jul; 138(1):143-4. PubMed ID: 3110433 [TBL] [Abstract][Full Text] [Related]
7. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer. Br J Urol; 1985 Dec; 57(6):680-5. PubMed ID: 2867800 [TBL] [Abstract][Full Text] [Related]
8. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 28-1977. N Engl J Med; 1977 Jul; 297(2):102-7. PubMed ID: 405588 [No Abstract] [Full Text] [Related]
9. Acute nonlymphocytic leukemia after thiotepa instillation into the bladder: report of 2 cases and review of the literature. Silberberg JM; Zarrabi MH J Urol; 1987 Aug; 138(2):402-3. PubMed ID: 3110436 [TBL] [Abstract][Full Text] [Related]
10. [Fatal bone marrow aplasia due to endovesical thio-tepa]. Navas P; Grasset D J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):489-91. PubMed ID: 4216649 [No Abstract] [Full Text] [Related]
14. [Effects of intravesical instillation of antitumor agents on bladder cancer]. Tomiyama T Nihon Hinyokika Gakkai Zasshi; 1972 Jul; 63(7):497-518. PubMed ID: 4628074 [No Abstract] [Full Text] [Related]
15. Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa. Wood DP; Streem SB; Levin HS J Urol; 1988 Jan; 139(1):130-1. PubMed ID: 3121867 [TBL] [Abstract][Full Text] [Related]
16. Intravesical thiotepa versus mitomycin C in patients with Ta, T1 and TIS transitional cell carcinoma of the bladder: a phase III prospective randomized study. Heney NM; Koontz WW; Barton B; Soloway M; Trump DL; Hazra T; Weinstein RS J Urol; 1988 Dec; 140(6):1390-3. PubMed ID: 3143016 [TBL] [Abstract][Full Text] [Related]
19. Acute nonlymphocytic leukemia following bladder instillations with thiotepa. Easton DJ; Poon MA Can Med Assoc J; 1983 Sep; 129(6):578-9. PubMed ID: 6411320 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy in the management of bladder tumours. Gibson GR Aust N Z J Surg; 1969 Feb; 38(3):281-3. PubMed ID: 4975184 [No Abstract] [Full Text] [Related] [Next] [New Search]